Subscribe to RSS
DOI: 10.1055/s-2002-34395
Isolation of Acyl-CoA:Cholesterol Acyltransferase Inhibitor from Persicaria vulgaris
Publication History
Received: January 10, 2002
Accepted: May 25, 2002
Publication Date:
30 September 2002 (online)
Abstract
In the course of our search for Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors from natural sources, a new type of ACAT inhibitor was isolated from the methanol extract of Persicaria vulgaris. On the basis of spectral evidence, the structure of the active compound was identified as pheophorbide A. Pheophorbide A inhibited ACAT activity with an IC50 value of 1.1 μg/ml in an enzyme assay using rat liver microsomes with a dose dependent fashion.
References
- 1 Suckling K E, Stange E F. Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. J. Lipid Res.. 1985; 26 647-71
-
2 Stange E F, Dietschy J M. Cholesterol absorption and metabolism by the intestinal epithelium. In: Danielsson H, Sjövall J, editors
New Comprehensive Biochemistry . Vol.12 Sterols and Bile Acids: Elsevier Science Publishers 1985: 121-49 - 3 Ross R. The pathogenesis of atherosclerosis an update. New Engl. J. Med.. 1986; 314 488-500
- 4 Sliskovic D R, White A D. Therapeutic potential of ACAT inhibitors as lipid lowering and antiatherosclerotic agents. Trends in Pharmacol. Sci.. 1991; 12 194-9
- 5 Chang S u. New Medical College. Dictionary of Chinese Crude Drugs. Shanghai Scientific Techonologic Publishers Shanghai; 1977
- 6 Schwikkard S L, Mulholland A D, Hutchings A. Pheophytins from Tupara fischeri . Phytochemistry. 1998; 49 2391-4
- 7 Tomoda H, Nishida H, Kim Y K, Obata R, Sunazuka T, Omura S. Relative and absolute stereochemistry of pyripyropene A, a potent, bioavailable inhibitor of Acyl-CoA:cholesterol acyltransferase (ACAT) J. Am. Chem. Soc.. 1994; 116 12 097-8
- 8 Sakata K, Yamamoto K, Ishikawa H, Yagi A, Etoh H, Ina K. Chlorophyllone-A, a new pheophorbide-a related compound isolated from Ruditapes philippinarum as an antioxidative compound. Tetrahedron Lett.. 1990; 31 1165-8
- 9 Chernomorsky S, Segelman A, Poretz R. Effect of dietary chlorophyll derivatives on mutagenesis and tumor cell growth. Teratog. Carcinog. Mutagen.. 1999; 19 313-22
- 10 Ohshima T, Hirata M, Oda T, Sasaki A, Shiratsuchi M. Pheophorbide a, a potent endothelin receptor antagonist for both ETA and ETB subtype. Chem. Pharm. Bull.. 1994; 42 2174-6
- 11 Heinrich M, Bork P M, Schmitz M L, Rimpler H, Frei B, Sticher O. Pheophorbide a from Solanum diflorum interferes with NF-kappa B activation. Planta Med.. 2001; 67 156-7
- 12 Kim Y K, Lee H W, Son K H, Kwon B M, Jeong T S, Lee D H, Shin J, Seo Y, Kim S U, Bok S H. GERI-BP002-A, novel inhibitor of Acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus F93. J. Antibiotics. 1996; 49 31-6
- 13 Rho M -C, Toyoshima M, Hayashi M, Uchida R, Shiomi K, Komiyama K, Omura S. Enhancement of drug accumulation by andrastin A produced by Penicillium sp. FO-3929 in vincristine-resistant KB cells. J. Antibiotics. 1998; 51 68-72
Young-Kook Kim Ph. D.
Cardiovascular Research Laboratory
Korea Research Institute of Bioscience and Biotechnology
Taejon 305-333, Korea
Phone: +82-42-860-4556,
Fax: +82-42-861-2675
Email: kimyk@mail.kribb.re.kr